{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T21:18:26Z","timestamp":1775337506414,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13014-017-0929-2","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T12:12:37Z","timestamp":1512562357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Radiotherapy plus temozolomide in elderly patients with glioblastoma: a \u201creal-life\u201d report"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-4487","authenticated-orcid":false,"given":"J.","family":"Biau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Chautard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"De Schlichting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dupic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fogli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"M\u00fcller-Barth\u00e9l\u00e9my","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dalloz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F.","family":"Dillies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Durando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Godfraind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Verrelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"key":"929_CR1","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0140-6736(11)61346-9","volume":"379","author":"D Ricard","year":"2012","unstructured":"Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, Delattre J-Y. Primary brain tumours in adults. Lancet. 2012;379:1984\u201396.","journal-title":"Lancet"},{"key":"929_CR2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl). 2016;131:803\u201320.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"Suppl 4","key":"929_CR3","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro-Oncol. 2015;17(Suppl 4):iv1\u2013iv62.","journal-title":"Neuro-Oncol"},{"key":"929_CR4","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/cncr.21539","volume":"104","author":"I Chakrabarti","year":"2005","unstructured":"Chakrabarti I, Cockburn M, Cozen W, Wang Y-P, Preston-Martin S. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999. Cancer. 2005;104:2798\u2013806.","journal-title":"Cancer"},{"key":"929_CR5","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa065901","volume":"356","author":"F Keime-Guibert","year":"2007","unstructured":"Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med. 2007;356:1527\u201335.","journal-title":"N Engl J Med"},{"key":"929_CR6","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","volume":"22","author":"W Roa","year":"2004","unstructured":"Roa W, Brasher PMA, Bauman G, Anthes M, Bruera E, Chan A, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22:1583\u20138.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"929_CR7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","volume":"13","author":"A Malmstr\u00f6m","year":"2012","unstructured":"Malmstr\u00f6m A, Gr\u00f8nberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol. 2012;13:916\u201326.","journal-title":"Lancet Oncol"},{"key":"929_CR8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","volume":"13","author":"W Wick","year":"2012","unstructured":"Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol. 2012;13:707\u201315.","journal-title":"Lancet Oncol"},{"key":"929_CR9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.radonc.2005.03.004","volume":"75","author":"CAM Marijnen","year":"2005","unstructured":"Marijnen CAM, van den Berg SMP, van Duinen SG, Voormolen JHC, Noordijk EM. Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: a retrospective single institution analysis. Radiother. Oncol. J. Eur. Soc. Ther. Radiol Oncol. 2005;75:210\u20136.","journal-title":"Radiol Oncol"},{"key":"929_CR10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11060-016-2294-7","volume":"131","author":"ND Arvold","year":"2017","unstructured":"Arvold ND, Cefalu M, Wang Y, Zigler C, Schrag D, Dominici F. Comparative effectiveness of radiotherapy with vs. without temozolomide in older patients with glioblastoma. J Neuro-Oncol. 2017;131:301\u201311.","journal-title":"J Neuro-Oncol"},{"key":"929_CR11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11060-015-1923-x","volume":"125","author":"G Lombardi","year":"2015","unstructured":"Lombardi G, Pace A, Pasqualetti F, Rizzato S, Faedi M, Anghileri E, et al. Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology). J Neuro-Oncol. 2015;125:359\u201367.","journal-title":"J Neuro-Oncol"},{"key":"929_CR12","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.21873\/anticanres.11052","volume":"36","author":"BK Shah","year":"2016","unstructured":"Shah BK, Bista A, Sharma S. Survival trends in elderly patients with Glioblastoma in the United States: a population-based study. Anticancer Res. 2016;36:4883\u20136.","journal-title":"Anticancer Res"},{"key":"929_CR13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11060-016-2093-1","volume":"128","author":"E Franceschi","year":"2016","unstructured":"Franceschi E, Depenni R, Paccapelo A, Ermani M, Faedi M, Sturiale C, et al. Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study. J Neuro-Oncol. 2016;128:157\u201362.","journal-title":"J Neuro-Oncol"},{"key":"929_CR14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","volume":"376","author":"JR Perry","year":"2017","unstructured":"Perry JR, Laperriere N, O\u2019Callaghan CJ, Brandes AA, Menten J, Phillips C, et al. Short-course radiation plus Temozolomide in elderly patients with Glioblastoma. N Engl J Med. 2017;376:1027\u201337.","journal-title":"N Engl J Med"},{"key":"929_CR15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ctrv.2012.05.008","volume":"39","author":"N Laperriere","year":"2013","unstructured":"Laperriere N, Weller M, Stupp R, Perry JR, Brandes AA, Wick W, et al. Optimal management of elderly patients with glioblastoma. Cancer Treat Rev. 2013;39:350\u20137.","journal-title":"Cancer Treat Rev"},{"key":"929_CR16","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ctrv.2011.12.010","volume":"38","author":"C Chargari","year":"2012","unstructured":"Chargari C, Feuvret L, Bauduceau O, Ricard D, Cuenca X, Delattre J-Y, et al. Treatment of elderly patients with glioblastoma: from clinical evidence to molecular highlights. Cancer Treat Rev. 2012;38:988\u201395.","journal-title":"Cancer Treat Rev"},{"key":"929_CR17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"929_CR18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459\u201366.","journal-title":"Lancet Oncol"},{"key":"929_CR19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1200\/JCO.2016.70.7562","volume":"35","author":"EP Sulman","year":"2017","unstructured":"Sulman EP, Ismaila N, Armstrong TS, Tsien C, Batchelor TT, Cloughesy T, et al. Radiation therapy for Glioblastoma: American Society of Clinical Oncology clinical practice guideline endorsement of the American Society for Radiation Oncology guideline. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35:361\u20139.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"929_CR20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11060-016-2331-6","volume":"131","author":"J Huang","year":"2017","unstructured":"Huang J, Samson P, Perkins SM, Ansstas G, Chheda MG, DeWees TA, et al. Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base. J Neuro-Oncol. 2017;131:593\u2013601.","journal-title":"J Neuro-Oncol"},{"key":"929_CR21","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1200\/JCO.2012.47.6952","volume":"31","author":"PJ Goodwin","year":"2013","unstructured":"Goodwin PJ, Ballman KV, Small EJ, Cannistra SA. Evaluation of treatment benefit in journal of clinical oncology. J Clin Oncol Off J Am Soc Clin Oncol. 2013;31:1123\u20134.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"929_CR22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/bjc.2013.725","volume":"110","author":"CM Booth","year":"2014","unstructured":"Booth CM, Tannock IF. Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br J Cancer. 2014;110:551\u20135.","journal-title":"Br J Cancer"},{"key":"929_CR23","doi-asserted-by":"crossref","unstructured":"Feuvret L, Antoni D, Biau J, Truc G, No\u00ebl G, Mazeron J-J. [Guidelines for the radiotherapy of gliomas]. Cancer Radiother J Soc Francaise Radiother Oncol. 2016;20 Suppl:S69-S79.","DOI":"10.1016\/j.canrad.2016.07.008"},{"key":"929_CR24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijrobp.2009.10.048","volume":"79","author":"MW McDonald","year":"2011","unstructured":"McDonald MW, H-KG S, Curran WJ, Crocker IR. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. Int J Radiat Oncol Biol Phys. 2011;79:130\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"929_CR25","first-page":"298","volume":"6","author":"AG Wernicke","year":"2016","unstructured":"Wernicke AG, Smith AW, Taube S, Mehta MP. Glioblastoma: radiation treatment margins, how small is large enough? Pract. Radiat Oncol. 2016;6:298\u2013305.","journal-title":"Radiat Oncol"},{"key":"929_CR26","first-page":"360","volume":"49","author":"KL McDonald","year":"2013","unstructured":"McDonald KL, Rapkins RW, Olivier J, Zhao L, Nozue K, Lu D, et al. The T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients. Eur J Cancer Oxf Engl 1990. 2013;49:360\u20138.","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"929_CR27","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1002\/cncr.27570","volume":"118","author":"JG Scott","year":"2012","unstructured":"Scott JG, Bauchet L, Fraum TJ, Nayak L, Cooper AR, Chao ST, et al. Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer. 2012;118:5595\u2013600.","journal-title":"Cancer"},{"key":"929_CR28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10143-014-0528-8","volume":"37","author":"S Zouaoui","year":"2014","unstructured":"Zouaoui S, Darlix A, Fabbro-Peray P, Mathieu-Daud\u00e9 H, Rigau V, Fabbro M, et al. Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France. Neurosurg Rev. 2014;37:415\u201323. discussion 423-424","journal-title":"Neurosurg Rev"},{"key":"929_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3171\/2013.9.JNS13877","volume":"120","author":"A Noorbakhsh","year":"2014","unstructured":"Noorbakhsh A, Tang JA, Marcus LP, McCutcheon B, Gonda DD, Schallhorn CS, et al. Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis. J Neurosurg. 2014;120:31\u20139.","journal-title":"J Neurosurg"},{"key":"929_CR30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00701-002-1030-6","volume":"145","author":"V Vuorinen","year":"2003","unstructured":"Vuorinen V, Hinkka S, F\u00e4rkkil\u00e4 M, J\u00e4\u00e4skel\u00e4inen J. Debulking or biopsy of malignant glioma in elderly people - a randomised study. Acta Neurochir. 2003;145:5\u201310.","journal-title":"Acta Neurochir"},{"key":"929_CR31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2014.09.013","volume":"91","author":"G Minniti","year":"2015","unstructured":"Minniti G, Scaringi C, Lanzetta G, Terrenato I, Esposito V, Arcella A, et al. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis. Int J Radiat Oncol Biol Phys. 2015;91:109\u201315.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"929_CR32","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ijrobp.2017.03.037","volume":"98","author":"D Guedes de Castro","year":"2017","unstructured":"Guedes de Castro D, Matiello J, Roa W, Ghosh S, Kepka L, Kumar N, et al. Survival outcomes with short-course radiation therapy in elderly patients with Glioblastoma: data from a randomized phase 3 trial. Int J Radiat Oncol Biol Phys. 2017;98:931\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"929_CR33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijrobp.2011.06.1992","volume":"83","author":"G Minniti","year":"2012","unstructured":"Minniti G, Lanzetta G, Scaringi C, Caporello P, Salvati M, Arcella A, et al. Phase II study of short-course radiotherapy plus concomitant and adjuvant Temozolomide in elderly patients with Glioblastoma. Int J Radiat Oncol Biol Phys. 2012;83:93\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"929_CR34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11060-008-9689-z","volume":"91","author":"G Minniti","year":"2009","unstructured":"Minniti G, De Sanctis V, Muni R, Rasio D, Lanzetta G, Bozzao A, et al. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. J Neuro-Oncol. 2009;91:95\u2013100.","journal-title":"J Neuro-Oncol"},{"key":"929_CR35","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1200\/JCO.2011.34.8086","volume":"29","author":"J G\u00e1llego P\u00e9rez-Larraya","year":"2011","unstructured":"G\u00e1llego P\u00e9rez-Larraya J, Ducray F, Chinot O, Catry-Thomas I, Taillandier L, Guillamo J-S, et al. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29:3050\u20135.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"929_CR36","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1200\/jco.2013.31.15_suppl.2020","volume":"31","author":"G Reyes-Botero","year":"2013","unstructured":"Reyes-Botero G, Honnorat J, Chinot OL, Taillandier L, Catry-Thomas I, Barriere J, et al. Temozolomide plus bevacizumab in elderly patients with newly diagnosed glioblastoma and poor performance status: an Anocef phase II trial. J Clin Oncol. 2013;31:2020.","journal-title":"J Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-017-0929-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T22:20:34Z","timestamp":1603491634000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-017-0929-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1186\/s13014-017-0929-2","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"197"}}